🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard Gilson

Central and North West London NHS Foundation Trust

ORCID: 0000-0002-9572-193X

Also affiliated with Centre for Global Health Research, Mortimer Market Centre, University College London

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT”.

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

Health Technology Assessment(2020)10.3310/hta24470

N/A

1.6DataRank · unranked

33 citations

Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L. Murray, Jade Meadows +10 more

A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groups

International Journal of Cancer(2022)10.1002/ijc.34199

N/A

0.723DataRank · unranked

123 citations

Ashish A. Deshmukh, Ryan Suk, Jennifer M. Roberts, Richard Gilson, Naomi Jay +3 more

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Infectious Diseases and Therapy(2023)10.1007/s40121-023-00789-y

N/A

0.602DataRank · unranked

12 citations

Morgan J. Katz, Adit A. Ginde, Kavita Juneja, Monica Ramchandani, Joshua T. Schiffer +13 more

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV

The Lancet HIV(2021)10.1016/s2352-3018(21)00099-0

N/A

0.568DataRank · unranked

43 citations

Aljawharah Alrubayyi, Chloe Rees-Spear, Natasha Fisher-Pearson, Sarah Griffith, Luke Muir +10 more

Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT

Health Technology Assessment(2021)10.3310/hta25270

N/A

0.499DataRank · unranked

11 citations

Anna Glasier, Lisa McDaid, Andrew Radley, Susan Patterson, Paula Baraitser +12 more

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Wellcome Open Research(2021)10.12688/wellcomeopenres.16594.1

N/A

0.292DataRank · unranked

6 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease

Nature Communications(2025)10.1038/s41467-025-67174-w

N/A

0.208DataRank · unranked

3 citations

Tomke Arand, Ha Gyu-Thomas Seong, Christian Heuss, Margaret Tulessin, Zhiqing Wang +49 more

Impact of anal precancer screening on patient-reported outcomes among men-who-have-sex-with-men living with HIV: a scoping review

European Journal of Cancer Prevention(2026)10.1097/cej.0000000000001001

N/A

0DataRank · unranked

0 citations

Yomna Gharib, Deirdre Sally, Shema Tariq, Richard Gilson, Emmi Suonpera

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

medRxiv(2021)10.1101/2021.01.22.21250208

N/A

0DataRank · unranked

0 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more

Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles

iScience(2022)10.1016/j.isci.2022.105862

N/A

0DataRank · unranked

25 citations

Aljawharah Alrubayyi, Rosemarie Ford, Noshin Hussain, Pehuén Pereyra Gerber, Hiu-Long Shum +25 more

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00484-5

N/A

0DataRank · unranked

7 citations

Hermaleigh Townsley, Joel Hellewell, Joshua Gahir, Marianne Shawe‐Taylor, David Greenwood +39 more